Anthony L Asher, MD, FACS
Carolinas HealthCare System’s Neurosciences Institute has recently invested in a state-of-the art medical device that will assist surgeons in the removal of tumors or diseased brain tissue that may have been previously considered inoperable. The new technology demonstrates the institute’s commitment to provide the most advanced and successful treatment for some of the most complex structural brain diseases.
The technology is NeuroBlate, one of the few systems that uses light energy from a laser to burn and destroy the abnormal tissue with precise accuracy, guided by MRI-imaging (laser guided ablation). The device monitors the brain using 3D, real-time procedural imaging to support the surgeon's clinical decision-making.
Anthony L. Asher, MD, FACS, neurosurgeon and co-medical director of the Carolinas HealthCare System Neurosciences Institute, says this technology will propel the Neurosciences Institute to the forefront of advanced care in brain tumor surgery.
“Laser-guided ablation enables our surgeons to perform precise procedures in locations where it would have been extremely difficult or impossible before,” Dr. Asher said. “Specifically, this technique will be especially effective in patients whose tumors are located deep in the brain that are generally difficult to access and treat using conventional methods. We will be able to offer hope to patients who previously had limited treatment alternatives.”
With this procedure, patients will have the benefit of returning home faster than with traditional brain surgery. For some, there will be an extension of survival or improved prognosis for functional recovery. In centers that are currently using this technology, significant reductions in wound and neurologic morbidity, hospital costs, length of surgery and length of stay for benign and malignant tumor surgery have been observed.
Surgeons plan to start using the NeuroBlate in October of 2014. They will be the first in the region to offer this technology to patients.